New data from Phase 2a clinical trial evaluating atebimetinib + mGnP in first-line pancreatic cancer will be presented in an oral session by Dr. Peter Vu, UC San Diego Health - - The ASCO presentation ...
CHINA DAILY Yunnan Baiyao Group, a century-old pharmaceutical brand based in Southwest China's Yunnan province, continues to ...
Background: Cachexia is a common complication of heart failure (HF) and is associated with high mortality. Growth differentiation factor 15 (GDF15) regulates food intake and can cause cancer cachexia.